PerkinElmer Q4 Revenues Flat | GenomeWeb

NEW YORK (GenomeWeb) – PerkinElmer reported after the close of the market on Thursday that fourth-quarter revenues were essentially flat compared to the same period a year ago.

For the three months ended Jan. 3, the company posted Q4 revenues of $608.1 million, slightly down from $608.4 million for the year-ago period, and falling short of analysts' consensus estimate of $617.5 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.